NCT04999007 Artificial Intelligence Assists Surgeons' Decision Making
| NCT ID | NCT04999007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jichao Qin |
| Condition | Rectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 616 participants |
| Start Date | 2021-09-02 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 616 participants in total. It began in 2021-09-02 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.
Eligibility Criteria
Inclusion Criteria: 1. Aged older than 18 years and younger than 85 years. 2. Primary rectal adenocarcinoma confirmed by preoperative pathology result. 3. Expected curative resection via total mesorectal excision procedure. 4. American Society of Anesthesiologists (ASA) class I, II, or III. 5. Written informed consent. Exclusion Criteria: 1. Pregnant or breastfeeding women. 2. Severe mental disorder or language communication disorder. 3. Hartmann surgery or colostomy is performed intraoperatively. 4. Interrupted of surgery for more than 30 minutes due to any cause. 5. Malignant tumors with other organs
Contact & Investigator
Jichao Qin, MD
PRINCIPAL INVESTIGATOR
Huazhong University of Science and Technology
Frequently Asked Questions
Who can join the NCT04999007 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Rectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04999007 currently recruiting?
Yes, NCT04999007 is actively recruiting participants. Contact the research team at jcqin@tjh.tjmu.edu.cn for enrollment information.
Where is the NCT04999007 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT04999007 clinical trial?
NCT04999007 is sponsored by Jichao Qin. The principal investigator is Jichao Qin, MD at Huazhong University of Science and Technology. The trial plans to enroll 616 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.